One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
- :
Price : 100$- Special Price : 50$
Bimekizumab treatment in patients with active axial spondyloarthritis: 52-week efficacy and safety from the randomised parallel phase 3 BE MOBILE 1 and BE MOBILE 2 studies
doi : 10.1136/ard-2023-224803
Annals of the Rheumatic Diseases collection on osteoarthritis (2018–2023): hopes and disappointments
doi : 10.1136/ard-2023-224840
Selectivity, efficacy and safety of JAKinibs: new evidence for a still evolving story
doi : 10.1136/ard-2023-223850
Long-term mortality in treated-to-target RA and UA: results of the BeSt and IMPROVED cohort
doi : 10.1136/ard-2023-224814
Abatacept and non-melanoma skin cancer in patients with rheumatoid arthritis: a comprehensive evaluation of randomised controlled trials and observational studies
doi : 10.1136/ard-2023-224356
Rheuma-VOR study: optimising healthcare of rheumatic diseases by multiprofessional coordinating centres
doi : 10.1136/ard-2023-224205
Specific descriptions of axial involvement are associated with radiographic damage development after 2 years in psoriatic arthritis patients
doi : 10.1136/ard-2023-224501
Card9/neutrophil signalling axis promotes IL-17A-mediated ankylosing spondyliti
doi : 10.1136/ard-2022-223146
Efficacy and safety of avacopan in patients with ANCA-associated vasculitis receiving rituximab in a randomised trial
doi : 10.1136/ard-2023-224816
Rituximab as maintenance therapy for ANCA-associated vasculitides: pooled analysis and long-term outcome of 277 patients included in the MAINRITSAN trials
doi : 10.1136/ard-2023-224623
Extracting immunological and clinical heterogeneity across autoimmune rheumatic diseases by cohort-wide immunophenotypin
doi : 10.1136/ard-2023-224537
Ultra-rare genetic variation in relapsing polychondritis: a whole-exome sequencing study
doi : 10.1136/ard-2023-224732
HLA-DRB1 and HLA-DQA1 associated with immunogenicity to adalimumab therapy in patients with rheumatoid arthritis
doi : 10.1136/ard-2023-223955
IL-17A inhibitor-induced leucocytoclastic vasculitis is responsive to IL-23 blockade in a psoriatic arthritis patient
doi : 10.1136/ard-2023-224604
IgM antibodies against acetylated proteins as a possible starting point of the anti-modified protein antibody response in rheumatoid arthritis
doi : 10.1136/ard-2023-224553
